In December 1921, Leonard Thompson was admitted to Toronto Normal Hospital so weak and emaciated that his father needed to carry him inside. Thompson was barely an adolescent, weighing all of 65 kilos, dying of diabetes. With so little to lose, he was an excellent candidate to be affected person No. 1 for a trial of the pancreatic extract that may come to be referred to as insulin.
The insulin did what as we speak we all know it could actually. “The boy grew to become brighter, extra lively, appeared higher and stated he felt stronger,” the crew of Toronto researchers and physicians reported in March 1922 in The Canadian Medical Association Journal. The article documented their use of insulin on six extra sufferers; it had seemingly reversed the illness in each case. As John Williams, a diabetes specialist in Rochester, New York, wrote of the first patient on whom he tried insulin later that yr, “The restoration of this affected person to his current state of well being is an achievement tough to document in temperate language. Definitely few recoveries from impending loss of life extra dramatic than this have ever been witnessed by a doctor.”
Of all of the surprise medicine within the historical past of drugs, insulin stands out as the closest parallel, in each operate and goal, to this century’s miracle of a metabolic drug: the GLP-1 agonist. Offered below now-familiar model names together with Ozempic, Wegovy, and Mounjaro, these new drugs for diabetes and weight problems have been hailed as a generational breakthrough that will someday stand with insulin remedy amongst “the greatest advances in the annals of chronic disease,” as The New Yorker put it in December.
But when that analogy is apt—and the correspondences are many—then a extra difficult legacy for GLP-1 medicine could possibly be within the works. Insulin, for its half, could have modified the world of drugs, however it additionally introduced alongside a raft of profound, unintended penalties. By 1950, the brand new remedy had tripled the variety of years that sufferers at a serious diabetes heart might anticipate to dwell after prognosis. It additionally saved these sufferers alive lengthy sufficient for them to expertise a wave of long-term issues. Leonard Thompson would die at 27 of pneumonia. Different younger women and men who shared his sickness additionally died far too younger, their veins and arteries ravaged by the illness, and maybe—there was no option to inform—by the insulin remedy and related dietary protocols that had saved them alive within the first place.
Within the a long time that adopted, diabetes, as soon as a uncommon dysfunction, would grow to be so widespread that complete drug-store aisles at the moment are devoted to its treatment-related paraphernalia. Roughly one in 10 Individuals is stricken. And regardless of a exceptional, ever-expanding armamentarium of drug therapies and medical gadgets, the illness—whether or not in its kind 1 or kind 2 kind—remains to be thought-about persistent and progressive. Sufferers dwell far longer than ever earlier than, but their situation remains to be anticipated to worsen with time, requiring ever extra aggressive therapies to maintain its harms in verify. One in each seven well being {dollars} is now spent on diabetes therapy, amounting to $800 million every day.
The appearance of insulin remedy additionally modified—I’d even say distorted—the associated medical science. In my newest ebook, Rethinking Diabetes, I doc how scientific investigators within the Nineteen Twenties abruptly shifted their focus from attempting to know the connection between weight loss program and illness to that between drug and illness. Physicians who had been treating diabetes with both fat-rich diets absent carbohydrates (which had been the accepted customary of care in each the U.S. and Europe) or very low-calorie “hunger” diets got here to depend on insulin as an alternative. Physicians would nonetheless insist that weight loss program is the cornerstone of remedy, however solely as an adjunct to the insulin remedy and within the expectation that any dietary recommendation they gave to sufferers can be ignored.
With the sudden rise of GLP-1 medicine on this decade, I fear {that a} comparable set of transformations might happen. Dietary remedy for weight problems and diabetes could also be sidelined in favor of highly effective prescription drugs—with little understanding of how the brand new medicine work and what they actually inform us concerning the mechanisms of illness. And all of that will proceed even supposing the long-term dangers of taking the medicine stay unsure.
“The ebullience surrounding GLP-1 agonists is tinged with uncertainty and even some foreboding,” Science reported in December, in its article declaring these weight problems remedies the journal’s Breakthrough of the Yr. “Like nearly all medicine, these blockbusters include uncomfortable side effects and unknowns.” But given the GLP-1 agonists’ astounding popularity, such cautionary notes are likely to sound like lip service. In any case, the FDA has deemed these medicine secure to be used, and docs have been prescribing merchandise on this class to diabetes sufferers for 20 years with little proof of long-term hurt.
But the GLP-1 agonists’ uncomfortable side effects have been studied rigorously solely out to seven years of use, and that was in a bunch of sufferers on exenatide—an early, far much less potent product on this class. The research provided no follow-up on the numerous members in that trial who had discontinued use. Different long-term research have adopted sufferers on the medicine for at the very least as a few years, however they’ve sought (and failed to seek out) solely very particular harms, corresponding to pancreatic cancer and breast cancer. Within the meantime, a 2023 survey discovered that greater than two-thirds of sufferers prescribed the newer GLP-1 agonists for weight reduction had stopped utilizing them inside a yr. Why did they stop? What occurred to them after they did?
The tales of Leonard Thompson and the numerous diabetes sufferers on insulin remedy who got here after could also be taken as a warning. The GLP-1 medicine have many traits in widespread with insulin. Each remedies grew to become very talked-about in a short time. Inside years of its discovery, insulin was being prescribed for primarily each diabetic affected person whose doctor might receive the drug. Each insulin and GLP-1 agonists had been initially developed as injectable remedies to regulate blood sugar. Each have an effect on urge for food and satiety, and each can have exceptional results on physique weight and composition. The GLP-1s, like insulin, deal with solely the signs of the issues for which they’re prescribed. Therefore, the advantages of GLP-1s, like these of insulin, are sustained solely with continued use.
The 2 remedies are additionally comparable in that they work, straight or not directly, by manipulating an unimaginably complicated physiological system. When current of their pure state—as insulin secreted from the pancreas, or GLP-1 secreted from the intestine (and maybe the brain)—they’re each concerned within the regulation of gas metabolism and storage, what’s technically referred to as gas partitioning. This technique tells our our bodies what to do with the macronutrients (protein, fats, and carbohydrates) within the meals we eat.
Chris Feudtner, a pediatrician, medical historian, and medical ethicist on the College of Pennsylvania, has described this hormonal regulation of gas partitioning as that of a “Council of Meals Utilization.” Organs talk with each other “through the language of hormones,” he wrote in Bittersweet, his historical past of the early years of insulin remedy and the transformation of kind 1 diabetes from an acute to a persistent illness. “The remainder of the physique’s tissues hearken to this ongoing dialogue and react to the general sample of hormonal messages. The meals is then used—for burning, rising, changing, storing, or retrieving.” Perturb that harmonious discourse, and the entire physiological ensemble of the human physique reverberates with corrections and counter-corrections.
For this reason the long-term penalties of utilizing these medicine could be so tough to fathom. Insulin remedy, as an example, didn’t simply decrease sufferers’ blood sugar; it restored their weight after which made them fatter nonetheless (even because it inhibited the voracious starvation that was a symptom of uncontrolled diabetes). Insulin remedy can also be accountable, at the very least partially, for diabetic issues—atherosclerosis and hypertension, as an example. That risk has been acknowledged in textbooks and journal articles however by no means settled as a scientific matter.
With the invention of insulin and its exceptional efficacy for treating kind 1 diabetes, diabetologists got here to embrace a therapeutic philosophy that’s nonetheless ascendant as we speak: Deal with the fast signs of the illness with drug remedy and assume that regardless of the future issues, they are often handled by different drug or surgical therapies. Sufferers with diabetes who develop atherosclerosis could prolong their lives with stents; these with hypertension could go on blood-pressure-lowering drugs.
An analogous sample might emerge for folks taking GLP-1s. (We see it already within the prospect of drug therapies for GLP-1-related muscle loss.) However the many scientific trials of the brand new weight problems remedies don’t and can’t have a look at what would possibly occur over a decade or extra of regular use, or what would possibly occur if the injections should be discontinued after that lengthy. We take as a right that if severe issues do emerge, far down that distant highway, or if the medicine should be discontinued due to uncomfortable side effects, newer remedies can be out there to unravel the issues or take over the job of weight upkeep.
Within the meantime, younger sufferers who keep on with therapy can anticipate to be on their GLP-1s for half a century. What would possibly occur throughout these a long time—and what would possibly occur if and after they should discontinue use—is presently unknowable, though, on the danger of sounding ominous, we’ll discover out.
Being pregnant is one other state of affairs that ought to generate severe questions. A recently published study discovered no elevated danger of beginning defects amongst ladies taking GLP-1 agonists for diabetes proper earlier than or throughout early being pregnant, as in contrast with these taking insulin, however beginning defects are only one apparent and simply observable impact of a drug taken throughout being pregnant. Youngsters of a mom with diabetes or weight problems are typically born bigger and have a higher risk of growing weight problems or diabetes themselves later in life. Using GLP-1 agonists throughout being pregnant could cut back—or exacerbate—that danger. Ought to the medicine be discontinued earlier than or throughout being pregnant, any sudden weight achieve (or regain) by the mom might equally have an effect on the well being of her little one. The results can’t be foreseen and may not manifest themselves till these youngsters attain their grownup years.
The rise of GLP-1 medicine can also distort our understanding of weight problems itself, in a lot the best way that insulin remedy distorted the pondering in diabetes analysis. With insulin’s discovery, physicians assumed that each one diabetes was an insulin-deficiency dysfunction, despite the fact that that is true as we speak for under 5 to 10 p.c of diabetic sufferers, these with kind 1. It took till the Sixties for specialists to simply accept that kind 2 diabetes was a really totally different dysfunction—a physiological resistance to insulin, inducing the pancreas to reply by secreting an excessive amount of of the hormone somewhat than not sufficient. And though the prognosis as we speak for a newly identified affected person with kind 2 diabetes is healthier than ever, physicians have but to determine whether or not the development and long-term issues of the illness are really inevitable, or whether or not they may be, in actual fact, a consequence of the insulin and different drug therapies which are used to regulate blood sugar, and even perhaps of the diets that sufferers are inspired to eat to accommodate these drug therapies.
Already, assumptions are being made concerning the mechanisms of GLP-1 agonists with out the rigorous testing essential to assess their validity. They’re broadly understood to work by inhibiting hunger and slowing the passage of meals from the abdomen—results that sound benign, as if the medicine had been little greater than pharmacological variations of a fiber-rich weight loss program. However modifications to a affected person’s urge for food and charge of gastric emptying solely occur to be simple to watch and research; they don’t essentially mirror the medicine’ most necessary or direct actions within the physique.
Once I spoke with Chris Feudtner about these points, we returned repeatedly to the idea that Donald Rumsfeld captured so nicely along with his framing of situational uncertainty: the identified unknowns and the unknown unknowns. “This isn’t a you-take-it-once-and-then-you’re-done drug,” Feudtner stated. “It is a new life-style, a brand new upkeep. We have now to look down the highway a bit with our sufferers to assist them suppose by way of a number of the future penalties.”
Sufferers, understandably, could have little time for a lecture on all that we don’t learn about these medicine. Weight problems itself comes with so many burdens—health-related, psychological, and social—that deciding, after a lifetime of wrestle, to take these medicine regardless of potential harms can at all times appear an affordable selection. Historical past tells us, although, that physicians and their sufferers must be cautious as they attempt to steadiness identified advantages towards a future, nonetheless distant, of unknown danger.
If you purchase a ebook utilizing a hyperlink on this web page, we obtain a fee. Thanks for supporting The Atlantic.
